Contact
Please use this form to send email to PR contact of this press release:
Apellis Pharmaceuticals (APLS) Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors to Seek Compensation for Alleged Wrongdoings
TO: